Vitamin E structure
|
Common Name | Vitamin E | ||
---|---|---|---|---|
CAS Number | 10191-41-0 | Molecular Weight | 430.706 | |
Density | 0.9±0.1 g/cm3 | Boiling Point | 485.9±0.0 °C at 760 mmHg | |
Molecular Formula | C29H50O2 | Melting Point | 2-4°C | |
MSDS | USA | Flash Point | 210.2±24.4 °C | |
Symbol |
GHS02, GHS06, GHS08 |
Signal Word | Danger |
Use of Vitamin EDL-alpha-Tocopherol is a synthetic vitamin E, with antioxidation effect. DL-alpha-Tocopherol protects human skin fibroblasts against the cytotoxic effect of UVB[1]. |
Name | Vitamin E |
---|---|
Synonym | More Synonyms |
Description | DL-alpha-Tocopherol is a synthetic vitamin E, with antioxidation effect. DL-alpha-Tocopherol protects human skin fibroblasts against the cytotoxic effect of UVB[1]. |
---|---|
Related Catalog | |
References |
Density | 0.9±0.1 g/cm3 |
---|---|
Boiling Point | 485.9±0.0 °C at 760 mmHg |
Melting Point | 2-4°C |
Molecular Formula | C29H50O2 |
Molecular Weight | 430.706 |
Flash Point | 210.2±24.4 °C |
Exact Mass | 430.381073 |
PSA | 29.46000 |
LogP | 11.90 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.495 |
Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|
Symbol |
GHS02, GHS06, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H225-H301 + H311 + H331-H370 |
Precautionary Statements | P210-P260-P280-P301 + P310-P311 |
Personal Protective Equipment | Eyeshields;Gloves |
Hazard Codes | Xi: Irritant; |
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S37/39 |
RIDADR | NONH for all modes of transport |
WGK Germany | 1 |
RTECS | GA8746000 |
~93% Vitamin E CAS#:10191-41-0 |
Literature: WO2004/46127 A1, ; Page 6-7 ; |
~58% Vitamin E CAS#:10191-41-0 |
Literature: Bulletin of the Polish Academy of Sciences, Chemistry, , vol. 37, # 5-6 p. 205 - 211 |
~% Vitamin E CAS#:10191-41-0 |
Literature: Bulletin of the Polish Academy of Sciences, Chemistry, , vol. 37, # 5-6 p. 205 - 211 |
Formulation approaches to improving the delivery of an antiviral drug with activity against seasonal flu.
Pharm. Dev. Technol. 20(2) , 169-75, (2015) The main objective of the present study was to develop formulations of noscapine hydrochloride hydrate with enhanced solubility and bioavailability using co-solvent- and cyclodextrin-based approaches.... |
|
Development of novel formulations to enhance in vivo transdermal permeation of tocopherol.
Acta. Pharm. 64(3) , 299-309, (2014) Tocopherol represents a big challenge for transdermal permeation owing to its extreme hydrophobicity and large molecular mass. The aim of the present study was to develop alpha-tocopherol (T) topical ... |
|
Coffee silverskin: a possible valuable cosmetic ingredient.
Pharm. Biol. 53(3) , 386-94, (2015) Currently, there is a great tendency in cosmetic area to use natural extracts. Coffee silverskin (CS) is the most abundant solid by-product generated during roasting of coffee processing.To evaluate d... |
(2R)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol |
DL-TOCOPHEROL |
dl-alpha-Tocopherol(E) |
ecyl) |
ephanyl |
alpha-Tocopherol |
(±)-α-Tocopherol |
(2R)-2,5,7,8-Tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]chroman-6-ol |
2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-, (2R)- |
vitamin |
A-TOCOPHEROL |
Irganox E 201 |
(2R)-2,5,7,8-Tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-6-chromanol |
MFCD00072051 |
DL-VITAMIN E |
dl-Alpha-Tocopherol |
EINECS 233-466-0 |
DL-α-Tocopherol |
(+/-)-alpha-Tocopherol,synthetic |